?

Kewalramani Reshma

CEO & President
Vertex Pharmaceuticals Incorporated
US, Boston [HQ]
CIK 1735944

Data Source

We automatically created this profile. The information was aggregated based on earnings call transcripts, insider forms and DEF 14A statements.

Latest Information

Shares :
121,374
Price per Share :
$419.92
Equivalence :
$50,967,370.08

Transaction History

  • S
    Form 4
    121,374 Shares After Transaction
    Value : $54,254,178.00
    Sold $6,795,294.00
    05/20/24
  • Footnotes:
    #1 Transaction made pursuant to Dr. Kewalramani's company approved trading plan under Rule 10b5-1, which was entered into on 02/07/2024.
  • S
    Form 4
    75,772 Shares After Transaction
    Value : $39,022,580.00
    Sold $7,826,970.00
    11/08/24
  • F
    Form 4
    162,271 Shares After Transaction
    Value : $68,598,442.54
    $3,489,718.70
    02/09/24
  • F
    Form 4
    136,507 Shares After Transaction
    Value : $58,942,357.53
    $4,052,780.94
    02/23/24
  • M
    Form 4
    122,939 Shares After Transaction
    Value : $23,054,750.67
    $293,484.45
    05/24/24

Get PRO Today.

PRO unlocks 8 more insider transactions made by Kewalramani Reshma

Start Free PRO trial Subscribe to PRO